US2023346289A1PendingUtilityA1

System for prognosticating patient outcomes and methods of using the same

Assignee: AUTEM MEDICAL LLCPriority: Apr 10, 2019Filed: Oct 10, 2022Published: Nov 2, 2023
Est. expiryApr 10, 2039(~12.7 yrs left)· nominal 20-yr term from priority
A61B 5/352A61B 5/256A61B 5/7275A61B 5/7285A61B 5/0245A61B 5/021A61B 5/4842A61B 5/029A61B 5/4848A61B 5/02405G16H 20/40A61B 5/0006G16H 50/70G16H 50/20G16H 40/67
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Systems and Methods for prognosticating an outcome in a patient by integrating a hemodynamic parameter (Hdp) monitoring system and a Radio Frequency generator synchronized by a processing system is disclosed. The system is capable of identifying health condition-specific Hdp variation values changes in a patient upon the exposure of low-energy amplitude modulated electromagnetic field frequencies. The construction of a library of frequencies can be used to more efficiently and effectively predict or treat an outcome in a patient by auto-tuning a treatment regimen specifically to the patient.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 - 22 . (canceled) 
     
     
         23 . A system for prognosticating an outcome for a patient, the system comprising:
 a monitoring system configured to detect a hemodynamic parameter exhibited by the patient;   a generator configured to output low-energy radio frequency electromagnetic fields; and   a processing system coupled to the monitoring system and the generator, the processing system configured to: 
 receive, via the monitoring system, a plurality of first values for the hemodynamic parameter during a nonexposure period in which the patient is not exposed to the low-energy radio frequency electromagnetic fields, 
 receive, via the monitoring system, a plurality of second values for the hemodynamic parameter during an exposure period in which the patient is exposed to the low-energy radio frequency electromagnetic fields, and 
 determine the outcome for the patient based on a comparison between the plurality of first values and the plurality of second values. 
   
     
     
         24 . The system of  claim 23 , wherein the outcome is selected from the group consisting of quality of life, survival, and hospital admission. 
     
     
         25 . The system of  claim 23 , wherein the low-energy radio frequency electromagnetic fields are configured to influence a cellular function of the patient. 
     
     
         26 . The system of  claim 23 , wherein a frequency of the low-energy radio frequency electromagnetic fields is from about 0.01 Hz to about 150 kHz. 
     
     
         27 . The system of  claim 23 , wherein a specific absorption rate of the low-energy radio frequency electromagnetic fields by the patient is less than about 1.6 mW/g. 
     
     
         28 . The system of  claim 23 , wherein the low-energy radio frequency electromagnetic fields comprise amplitude-modulated carrier signals. 
     
     
         29 . A method for prognosticating an outcome for a patient using a monitoring system configured to detect a hemodynamic parameter exhibited by the patient and a generator configured to output low-energy radio frequency electromagnetic fields, the method comprising:
 receiving, by a processing system, a plurality of first values for the hemodynamic parameter from the monitoring system during a nonexposure period in which the patient is not exposed to the low-energy radio frequency electromagnetic fields by the generator;   receiving, by the processing system, a plurality of second values for the hemodynamic parameter from the monitoring system during an exposure period in which the patient is exposed to the low-energy radio frequency electromagnetic fields by the generator; and   determining, by the processing system, the outcome for the patient based on a comparison between the plurality of first values and the plurality of second values.   
     
     
         30 . The method of  claim 29 , wherein the outcome is selected from the group consisting of quality of life, survival, and hospital admission. 
     
     
         31 . The method of  claim 29 , wherein the low-energy radio frequency electromagnetic fields are configured to influence a cellular function of the patient. 
     
     
         32 . The method of  claim 29 , wherein a frequency of the low-energy radio frequency electromagnetic fields is from about 0.01 Hz to about 150 kHz. 
     
     
         33 . The method of  claim 29 , wherein a specific absorption rate of the low-energy radio frequency electromagnetic fields by the patient is less than about 1.6 mW/g. 
     
     
         34 . The method of  claim 29 , wherein the low-energy radio frequency electromagnetic fields comprise amplitude-modulated carrier signals.

Join the waitlist — get patent alerts

Track US2023346289A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.